« Back to Record
Taieb, J., Fratté, S., Levaché, C. B., Saban-Roche, L., Thaler, J., Petersen, L. N., Bridgewater, J., Perkins, G., Lepage, C., Van Cutsem, E., Zaanan, A., Balogoun, R., Laurent-Puig, P., Le Malicot, K., Tabernero, J., Mini, E., Folprecht, G., Van Laethem, J.-L., Emile, J.-F., & Mulot, C. (2017). Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients. Annals of oncology, 28(4), mdw687, 824-830. doi:10.1093/annonc/mdw687
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/253451



